Skip to content
Lower risk Drug recall · FDA · Published September 28, 2023

Padagis Gynazole-1 Vaginal Cream Recall: Incorrect Silica Formulation

Padagis recalls Gynazole-1 vaginal cream due to incorrect silica formulation. This may cause irritation or other issues. Contact for return instructions.

🇺🇸 FDA recall #D-0081-2024DrugPadagis ›
Take action

Contact the company

Recalling firmPadagis US LLC3940 Quebec Ave N · Minneapolis, MN 55427-1244
✎ GovInfoNow plain-language explainer

Padagis is recalling Gynazole-1 vaginal cream because it was made with hydrophilic silica instead of hydrophobic silica as required. This could lead to irritation or other issues for users. Read more at govinfonow.com/recall/33092-padagis-gynazole-1-vaginal-cream-recall-incorrect-silica-formulation.

Source Summary by GovInfoNow · govinfonow.com/recall/33092-padagis-gynazole-1-vaginal-cream-recall-incorrect-silica-formulation · Updated August 17, 2026 · FDA enforcement record: FDA #D-0081-2024

Cite this page

“Padagis Gynazole-1 Vaginal Cream Recall: Incorrect Silica Formulation.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33092-padagis-gynazole-1-vaginal-cream-recall-incorrect-silica-formulation. Based on FDA recall #D-0081-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0081-2024%22&limit=1).

Padagis US LLC, acting voluntarily, recalled Gynazole-1 vaginal cream nationwide on Sept. 28, 2023, after the FDA announced the product was manufactured with incorrect silica formulation. The recall affects 10,512 cartons distributed across the United States.

How to tell if you have it

  • Brand: Padagis
  • Product: Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-filled applicator
  • NDC: 45802-396-01
  • Lot#: 164185
  • Exp. Date: 4/2024

The hazard

The product was manufactured using Hydrophilic Colloidal Silica instead of the required Hydrophobic Colloidal Silica, according to the FDA recall record.

Context

GovInfoNow's records show Padagis US LLC has conducted seven other recalls since Dec. 27, 2021, including a June 23, 2026, Nystatin Cream recall for subpotent drug risk and a Feb. 6, 2025, Estradiol Gel recall involving defective containers. Other recent recalls of similar products include a Medline Silicone Cream recall (June 11, 2026) for formaldehyde risk and a Sun Pharmaceutical Diclofenac Gel recall (Jan. 27, 2026) for failed viscosity specifications.

How to tell if you have this one

Check for the product name 'Gynazole-1', 2% butoconazole nitrate vaginal cream, 5.8g per pre-filled applicator, packaged in 1 per carton. The lot number is 164185 with an expiration date of April 2024.

  • Brand
    Padagis
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the product name 'Gynazole-1', 2% butoconazole nitrate vaginal cream, 5.8g per pre-filled applicator, packaged in 1 per carton.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 41 days after the firm started it.

1. Firm started the recall: Sep 28, 202312. FDA classified it Class II: Oct 31, 202323. Published in FDA’s Enforcement Report: Nov 8, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0081-2024 (September 28, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0081-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA